Treatment Of Diabetes Is Different For Men And Women

Treatment Of Diabetes Is Different For Men And Women.
Widely Euphemistic pre-owned diabetes drugs have various things on men's and women's hearts, a novel learn suggests. Researchers examined how three commonly prescribed treatments for standard 2 diabetes non-natural 78 patients who were divided into three groups. One clique took metformin alone, the go along with group took metformin with an increment of rosiglitazone (sold under the trade-mark name Avandia) and the third group took metformin with the addition of Lovaza, a type of fish oil maa ko manforce khila ke choda. Metformin reduces blood sugar assembly by the liver and improves insulin sensitivity.

Rosiglitazone also improves insulin awareness and moves unencumbered fatty acids out of the blood. Lovaza lowers blood levels of another group of five-by-five called triglycerides. The researchers found that the drugs had very disparate and now and again opposite effects on the hearts of men and women, even as the drugs controlled blood sugar equally well in both genders windowsce. The library appears in the December emanate of the American Journal of Physiology - Heart and Circulatory Physiology.

Although metformin had glaring centre chattels in women, it caused the core metabolism of men to burn less sugar and more fats. Chronic ardent of fat by the affection results in harmful changes that can lead to verve failure, said the researchers, from the Washington University School of Medicine in St Louis carallumaburn. "Instead of making boldness metabolism more average in men, metformin desolate made it worse, looking even more get off on a diabetic heart," study ranking author Dr Robert Gropler said in a university news programme release.

And "But in women, metformin had the desired carry out - lowering corpulence metabolism and increasing glucose insight by the heart". Taking either rosiglitazone or Lovaza with metformin seemed to diminish some of the negative heart clobber of metformin alone in men. Taking rosiglitazone in summing-up to metformin further improved women's essence metabolism, compared to taking metformin alone.

The ell of Lovaza to metformin did not have a strong effect either modus operandi for men or women, the researchers said. "Our den suggests that we need to better define which therapies are optimal for women with diabetes and which ones are optimal for men," said Gropler, a professor of radiology. The con did not, however, validate a cause-and-effect component between the slip combinations and crux changes antehealth. It showed only an association.